NCT07458828 is a NA clinical trial of DAP-HAI-403 in Hair Damage, sponsored by Dong-A Pharmaceutical.

Who is sponsoring NCT07458828?

NCT07458828 is sponsored by Dong-A Pharmaceutical.

What drugs are being tested in NCT07458828?

Interventions in NCT07458828: DAP-HAI-403, Placebo.

What condition does NCT07458828 study?

NCT07458828 studies Hair Damage, Hair Health, Hair Strength.

Is NCT07458828 still recruiting?

NCT07458828 is currently completed. Last updated 9 March 2026.

Last reviewed 2026-03-09 · How we verify

NCT07458828

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health

Completed NA Last updated 9 March 2026

What this trial tests

NA trial testing DAP-HAI-403 in Hair Damage in 120 participants. Completed in 12 August 2025.

Timeline

23 January 2024

Primary endpoint
21 January 2025

12 August 2025

Quick facts

Lead sponsor	Dong-A Pharmaceutical
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	120
Start date	23 January 2024
Primary completion	21 January 2025
Estimated completion	12 August 2025
Sites	1 location across South Korea

Drugs / interventions tested

DAP-HAI-403
Placebo

Conditions studied

Hair Damage — all drugs for Hair Damage →
Hair Health — all drugs for Hair Health →
Hair Strength — all drugs for Hair Strength →

Sponsor

Dong-A Pharmaceutical — full company profile →

Who can join

Adults 19 to 60, any sex, with Hair Damage or Hair Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to evaluate the efficacy and safety of Hydrolyzed Keratin Peptide Powder in promoting hair health in adult with mild to moderate hair damage, compared to a placebo control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Dong-A Pharmaceutical trials

Trials by the same sponsor.

NCT03117153 — Effect of a Liquid Toothpaste on Periodontal Disease · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07458828 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dong-A Pharmaceutical
Last refreshed: 9 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07458828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing